Home/Drugs/Tanzisertib

Tanzisertib

tanzisertib

Phase 2a

Sponsor: Celgene

Indication: IPF

Mechanism of Action

JNK inhibitor

Target: JNK

Clinical Information

Clinical Trials (ClinicalTrials.gov)

No clinical trials found for tanzisertib.

Relevant Publications (PubMed)

No recent publications found for tanzisertib.

Validated Models

This drug has been validated in the following preclinical models: